State Board of Administration of Florida Retirement System lifted its holdings in PAREXEL International Co. (NASDAQ:PRXL) by 10.4% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 39,173 shares of the medical research company’s stock after acquiring an additional 3,690 shares during the quarter. State Board of Administration of Florida Retirement System owned approximately 0.08% of PAREXEL International worth $3,450,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also made changes to their positions in the company. World Asset Management Inc lifted its holdings in PAREXEL International by 0.3% during the 2nd quarter. World Asset Management Inc now owns 3,212 shares of the medical research company’s stock worth $279,000 after buying an additional 9 shares in the last quarter. 1st Global Advisors Inc. lifted its holdings in PAREXEL International by 0.4% during the 2nd quarter. 1st Global Advisors Inc. now owns 5,391 shares of the medical research company’s stock worth $469,000 after buying an additional 21 shares in the last quarter. Amalgamated Bank lifted its holdings in PAREXEL International by 0.6% during the 2nd quarter. Amalgamated Bank now owns 7,259 shares of the medical research company’s stock worth $631,000 after buying an additional 42 shares in the last quarter. Public Employees Retirement System of Ohio lifted its holdings in PAREXEL International by 4.5% during the 1st quarter. Public Employees Retirement System of Ohio now owns 1,713 shares of the medical research company’s stock worth $108,000 after buying an additional 73 shares in the last quarter. Finally, Texas Permanent School Fund lifted its holdings in PAREXEL International by 0.5% during the 2nd quarter. Texas Permanent School Fund now owns 37,062 shares of the medical research company’s stock worth $3,221,000 after buying an additional 169 shares in the last quarter. 87.45% of the stock is currently owned by institutional investors and hedge funds.

Shares of PAREXEL International Co. (NASDAQ:PRXL) opened at $88.08 on Wednesday. PAREXEL International Co. has a 1 year low of $51.16 and a 1 year high of $88.10. The company has a current ratio of 1.45, a quick ratio of 1.45 and a debt-to-equity ratio of 1.01.

PAREXEL International (NASDAQ:PRXL) last issued its earnings results on Monday, August 28th. The medical research company reported $1.02 EPS for the quarter, beating the consensus estimate of $0.94 by $0.08. The company had revenue of $557.20 million during the quarter, compared to analysts’ expectations of $537.59 million. PAREXEL International had a net margin of 4.62% and a return on equity of 19.95%. During the same quarter in the previous year, the company posted $0.94 EPS.

COPYRIGHT VIOLATION NOTICE: “PAREXEL International Co. (PRXL) Stake Lifted by State Board of Administration of Florida Retirement System” was reported by Daily Political and is the sole property of of Daily Political. If you are reading this story on another website, it was illegally stolen and republished in violation of US and international trademark & copyright laws. The correct version of this story can be read at https://www.dailypolitical.com/2017/11/15/parexel-international-co-prxl-stake-lifted-by-state-board-of-administration-of-florida-retirement-system.html.

Several research analysts have issued reports on the company. Zacks Investment Research raised PAREXEL International from a “hold” rating to a “buy” rating and set a $98.00 price objective on the stock in a report on Thursday, August 31st. BidaskClub downgraded PAREXEL International from a “strong-buy” rating to a “buy” rating in a report on Friday, July 28th. Two analysts have rated the stock with a sell rating, seven have given a hold rating and four have given a buy rating to the company’s stock. The company presently has an average rating of “Hold” and a consensus target price of $78.68.

About PAREXEL International

PAREXEL International Corporation (PAREXEL) is a biopharmaceutical outsourcing services company. The Company provides a range of expertise in clinical research, clinical logistics, medical communications, consulting, commercialization, and technology products and services to pharmaceutical, biotechnology and medical device industries.

Want to see what other hedge funds are holding PRXL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for PAREXEL International Co. (NASDAQ:PRXL).

Institutional Ownership by Quarter for PAREXEL International (NASDAQ:PRXL)

Receive News & Ratings for PAREXEL International Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PAREXEL International Co. and related companies with MarketBeat.com's FREE daily email newsletter.